Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany
- PMID: 33521511
- PMCID: PMC7841415
- DOI: 10.5414/ALX02225E
Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany
Abstract
Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.
Keywords: COVID-19 vaccination; allergy; anaphylaxis; polyethylene glycol; polysorbate 80; skin test.
© Dustri-Verlag Dr. K. Feistle.
Figures
References
LinkOut - more resources
Full Text Sources
Other Literature Sources